NDC 50090-8074-00 - acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-8074
- Requested NDC
- 50090-8074-00
- Package NDCs from labels
- 50090-8074-0, 50090-8074-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| acyclovir - A-S Medication Solutions | A-S Medication Solutions | 2026-09-18 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 85332671-0e3a-4445-a337-e1266886b9cf | 2026-07-08 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 499c6a98-0614-4ded-8526-909942bae8a4 | 2026-06-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 37a51d9c-1f39-4065-8c7d-6528ac6de91c | 2026-06-23 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Alembic Pharmaceuticals Inc. | 878615c2-09ea-44ce-8c30-7a7f16acb20c | 2026-06-18 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | db35fce0-d7a3-4589-ba60-d78cdb1119cb | 2026-06-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Redpharm Drug | 53cbca4d-3ddc-b11e-e063-6394a90a04fa | 2026-06-09 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | St. Mary's Medical Park Pharmacy | 1493e22d-455d-b613-e063-6294a90afede | 2026-06-04 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | dbdb7903-0991-413d-b1ad-ab0f1ae2d8f4 | 2026-06-04 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | db0a0ce5-dc39-4bd3-8b97-21ce9c9999f0 | 2026-05-27 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | 2b600b5d-ce91-461f-b9d1-75b969daf8e9 | 2026-05-21 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 0e78d5e8-ae2d-4e84-b8c2-6765b1299c12 | 2026-05-21 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Westminster Pharmaceuticals, LLC | f352a641-988e-4878-8016-2b69cd6ee548 | 2026-05-11 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir suspension | ACYCLOVIR | Atlantic Biologicals Corp. | 5105272f-cff8-8898-e063-6394a90aabb5 | 2026-05-04 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Torrent Pharmaceuticals Limited | 1c510390-fb00-4271-967d-0883a9d5e1fd | 2026-05-04 | Warnings, Adverse reactions | 197312 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Aryeh Pharma Corp | f60cc0c2-e0fe-406a-b5c0-90bc4b566bb3 | 2026-05-01 | Warnings, Adverse reactions | 197312 X4HES1O11F |
| acyclovir | ACYCLOVIR | Proficient Rx LP | d4729677-164b-41b8-bbc4-4e47346b0f72 | 2026-05-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | e8a0f9f8-294f-4dd6-bd55-10a6253f1aa8 | 2026-04-29 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 0990b625-5dfe-4810-b5b4-ac5948599e79 | 2026-04-27 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Sportpharm LLC | c561bf77-5b26-4f23-9d49-9d964b48f772 | 2026-04-24 | Warnings, Adverse reactions | ANDA205974 197312 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Modavar Pharmaceuticals LLC | c7317324-4654-4bcc-8edf-7b7cd8794d2e | 2026-04-24 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.